Medico Remedies Intrinsic Value
MEDICO • Healthcare
Current Stock Price
₹32.76
Primary Intrinsic Value
₹30.80
Market Cap
₹55.7 Cr
+4.3%
Upside
Median Value
₹34.17
Value Range
₹22 - ₹74
Assessment
Trading Near Calculated Value
Safety Margin
4.1%
MEDICO Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹30.80 | ₹24.64 - ₹36.96 | -6.0% | EPS: ₹1.40, Sector P/E: 22x |
| Book Value Method | asset | ₹74.12 | ₹66.71 - ₹81.53 | +126.3% | Book Value/Share: ₹37.06, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹65.52 | ₹58.97 - ₹72.07 | +100.0% | Revenue/Share: ₹103.53, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹65.52 | ₹58.97 - ₹72.07 | +100.0% | EBITDA: ₹19.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹27.31 | ₹21.85 - ₹32.77 | -16.6% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹22.40 | ₹20.16 - ₹24.64 | -31.6% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹21.98 | ₹19.78 - ₹24.18 | -32.9% | Revenue Growth: 9.4%, Adj P/E: 15.7x |
| ROE Based Valuation | profitability | ₹65.52 | ₹58.97 - ₹72.07 | +100.0% | ROE: 17.5%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹34.17 | ₹30.75 - ₹37.59 | +4.3% | EPS: ₹1.40, BVPS: ₹37.06 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
MEDICO Intrinsic Value Analysis
What is the intrinsic value of MEDICO?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Medico Remedies (MEDICO) is ₹34.17 (median value). With the current market price of ₹32.76, this represents a +4.3% variance from our estimated fair value.
The valuation range spans from ₹21.98 to ₹74.12, indicating ₹21.98 - ₹74.12.
Is MEDICO undervalued or overvalued?
Based on our multi-method analysis, Medico Remedies (MEDICO) appears to be trading near calculated value by approximately 4.3%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 1.90 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 17.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 9.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.47x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Medico Remedies
Additional stock information and data for MEDICO
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹5 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹8 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹6 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-11 Cr | ₹-20 Cr | Negative Cash Flow | 3/10 |